FormFactor CEO Mike Slessor Sells 16,002 Shares for $2 Million

FormFactor CEO Mike Slessor sold 16,002 shares for ~$2.1M (weighted-average sale price $130.95) on Aug. 14, 2026, trimming his direct stake by ~3% under a Rule 10b5-1 plan set on Aug. 19, 2025. He still owns 484,204 shares worth ~$63.72M as of the Aug. 14 close ($131.60). The disposal is small relative to his remaining holdings and, alongside strong company fundamentals noted (TTM revenue +18% YoY), is unlikely to change the near-term investment view materially.

Analysis

This is a low-signal filing: a 10b5-1 sale after a 335% one-year move is more about pre-set diversification than a change in operating view. The market risk is not the insider print itself; it is that FORM’s valuation now embeds a very clean continuation path, so any hiccup in wafer-test demand or margin normalization can compress the multiple fast.

Second-order, FORM is a leveraged expression of advanced-node complexity. If HBM, leading-edge logic, and advanced packaging remain capacity-constrained, probe-card intensity should stay elevated and the company can outgrow the broader semi-capex cycle. If those budgets pause, the revenue impact may lag by a quarter or two, but the stock can re-rate immediately because the current setup leaves little margin for disappointment.

Contrarian view: the consensus is likely overreacting to the insider sale while underweighting valuation risk. The more important tell is whether gross margin and operating margin can hold near current levels as growth normalizes; if either rolls over, the stock’s premium could mean-revert even if revenue is still growing. For holders, this is a position-management event, not a fundamental alarm.

Key Decisions for Investors

• Do not short FORM solely on this 10b5-1 filing; treat any opening weakness as noise unless the stock is down >3% while SOXX is flat or higher, in which case it becomes a tactical long for a 1-3 week mean reversion.
• For existing FORM longs, trim 10-20% or buy a 3-6 month put spread into strength: the setup is a high-multiple name where the first real miss on margin or guide could drive outsized de-rating.
• Relative-value hedge: short FORM vs long SOXX for 1-3 months if you want semis exposure but less single-name valuation risk; thesis fails if FORM continues to raise revenue guidance or holds operating margin above the current run-rate.
• Set an alert on next earnings for revenue growth and operating margin, not insider activity; a re-acceleration in either would invalidate the bearish valuation case and favor covering any hedge.
• If FORM trades below its post-event trendline and then reclaims it on volume, buy the dip rather than chase the headline — the filing itself is not a fundamental negative.